Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 3
2016 2
2017 4
2018 7
2019 5
2020 13
2021 14
2022 16
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry.
D'Erasmo L, Bini S, Casula M, Gazzotti M, Bertolini S, Calandra S, Tarugi P, Averna M, Iannuzzo G, Fortunato G, Catapano AL, Arca M; LIPIGEN HoFH group. D'Erasmo L, et al. Eur J Prev Cardiol. 2024 Feb 20:zwae036. doi: 10.1093/eurjpc/zwae036. Online ahead of print. Eur J Prev Cardiol. 2024. PMID: 38374534
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia.
Mulder JWCM, Tromp TR, Al-Khnifsawi M, Blom DJ, Chlebus K, Cuchel M, D'Erasmo L, Gallo A, Hovingh GK, Kim NT, Long J, Raal FJ, Schonck WAM, Soran H, Truong TH, Boersma E, Roeters van Lennep JE; Homozygous Familial Hypercholesterolemia International Clinical Collaborators. Mulder JWCM, et al. Among authors: d erasmo l. JAMA Cardiol. 2024 Apr 1;9(4):313-322. doi: 10.1001/jamacardio.2023.5597. JAMA Cardiol. 2024. PMID: 38353972
Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries.
Arca M, Celant S, Olimpieri PP, Colatrella A, Tomassini L, D'Erasmo L, Averna M, Zambon A, Catapano AL, Russo P. Arca M, et al. Among authors: d erasmo l. J Am Heart Assoc. 2023 Nov 7;12(21):e026550. doi: 10.1161/JAHA.122.026550. Epub 2023 Oct 18. J Am Heart Assoc. 2023. PMID: 37850449 Free PMC article.
ANGPTL3 Deficiency and Risk of Hepatic Steatosis.
D'Erasmo L, Di Martino M, Neufeld T, Fraum TJ, Kang CJ, Burks KH, Di Costanzo A, Minicocci I, Bini S, Maranghi M, Pigna G, Labbadia G, Zheng J, Fierro D, Montali A, Ceci F, Catalano C, Davidson NO, Lucisano G, Nicolucci A, Arca M, Stitziel NO. D'Erasmo L, et al. Circulation. 2023 Nov 7;148(19):1479-1489. doi: 10.1161/CIRCULATIONAHA.123.065866. Epub 2023 Sep 15. Circulation. 2023. PMID: 37712257
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study.
Catapano F, Galea N, Pambianchi G, D'Erasmo L, Borrazzo C, Cundari G, Marchitelli L, Maranghi M, Minicocci I, Di Costanzo A, Carbone I, Francone M, Arca M, Catalano C. Catapano F, et al. Among authors: d erasmo l. Radiol Med. 2023 Apr;128(4):445-455. doi: 10.1007/s11547-023-01610-z. Epub 2023 Mar 6. Radiol Med. 2023. PMID: 36877423 Free PMC article.
How ANGPTL3 Inhibition Will Help Our Clinical Practice?
Bini S, Tramontano D, Minicocci I, Di Costanzo A, Tambaro F, D'Erasmo L, Arca M. Bini S, et al. Among authors: d erasmo l. Curr Atheroscler Rep. 2023 Jan;25(1):19-29. doi: 10.1007/s11883-022-01076-w. Epub 2023 Jan 6. Curr Atheroscler Rep. 2023. PMID: 36607583 Review.
70 results